Yarrow Bioscience (YARW) Notes Payables (2020)
Yarrow Bioscience's (YARW) quarterly Notes Payables came in at $1.2 million in Q1 2020.
Powered by 
Analysis
Yarrow Bioscience (YARW) Notes Payables (2020) Analysis & Trends
Yarrow Bioscience (YARW) has reported Notes Payables for 1 consecutive years, with $1.2 million the latest figure, recorded in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Yarrow Bioscience | 25.92 Mn | 3.00 Mn | - |